1h Free Analyst Time
Speak directly to the analyst to clarify any post sales queries you may have.
Senior decision-makers in diagnostics and healthcare are facing a dynamic landscape shaped by shifting disease patterns and heightened demands for rapid, accurate solutions. The dengue testing market is evolving with new technologies, regulatory measures, and global health imperatives influencing supply chains and regional adoption strategies.
Market Snapshot: Dengue Testing Market Insights
The Dengue Testing Market grew from USD 527.02 million in 2024 to USD 558.61 million in 2025, at a CAGR of 5.77%, reaching USD 738.13 million by 2030. This growth reflects the sector’s response to global dengue outbreaks, pandemic-induced diagnostic enhancements, and sustained investment in infectious disease surveillance and laboratory modernization. The primary keyword, "dengue testing market," characterizes a sector defined by multidisciplinary innovation, operational resilience, and collaboration across industry, public health, and clinical stakeholders across major global regions.
Scope & Segmentation
- Test Types: Antibody tests (IgG, IgM), antigen tests (NS1 ELISA, NS1 rapid tests), and molecular tests (conventional PCR, real-time PCR)
- Technologies: Enzyme-linked immunosorbent assay (ELISA), lateral flow immunoassay (colloidal gold assay, fluorescent immunoassay), microarray technology, and polymerase chain reaction
- End Users: Clinics, diagnostic laboratories, hospitals, research institutes
- Product Types: Instruments (readers, thermal cyclers), software solutions, test kits
- Settings: Central laboratory, point of care
- Sample Types: Plasma, serum, whole blood
- Key Regional Markets: Americas (United States—California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio—Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (UK, Germany, France, Russia, Italy, Spain, UAE, Saudi Arabia, South Africa, and others), Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan)
- Covered Companies: Abbott Laboratories, F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Danaher Corporation, bioMérieux SA, QIAGEN N.V., Bio-Rad Laboratories, Siemens Healthineers AG, Meridian Bioscience Inc., Chembio Diagnostics Inc.
Key Takeaways for Decision-Makers
- Technological progress is driving adoption of rapid point-of-care platforms and advanced digital diagnostic solutions, enabling real-time interpretation and decentralized screening.
- Collaboration between technology developers, academic research centers, and contract manufacturers is facilitating faster assay development and regulatory alignment.
- Endpoint integration with telehealth and digital data systems is extending diagnostic reach to underserved communities and streamlining clinical workflows.
- Diversified supply chains and regional manufacturing hubs are emerging as priorities, helping organizations buffer against logistical disruptions.
- Disease surveillance and outbreak management are enhanced by multiplexed testing solutions capable of distinguishing dengue from other arboviruses.
- Strategic partnerships, robust R&D pipelines, and real-world field evaluations remain essential for product validation and sustainable global growth.
Tariff Impact: Navigating U.S. Trade Measures
In 2025, the United States introduced tariffs on key diagnostic reagents, assay components, and laboratory equipment used for dengue testing. Manufacturers have responded by reassessing supplier relationships, diversifying production, and forming regional alliances to manage incremental cost pressures and potential delays. These measures are also accelerating discussions around tariff exemptions for essential health sector supplies and fostering co-development initiatives for compliant assays.
Methodology & Data Sources
This report utilizes a dual-method research approach, combining structured interviews with key opinion leaders—such as laboratory directors, infectious disease specialists, and diagnostic executives—with systematic secondary reviews of scientific journals, regulatory publications, patent filings, and trade databases. All trends are validated through triangulation, peer review, and rigorous quality checks to ensure analytical accuracy.
Why This Report Matters
- Offers a comprehensive view of market shifts, technology trends, and regulatory factors impacting investment and operational strategies in dengue testing.
- Equips executives and procurement leaders with actionable intelligence to capitalize on emerging diagnostic innovations, strengthen supply chains, and match products with local needs.
- Enables competitive positioning by profiling leading firms’ capabilities, partnerships, and regional expansion strategies.
Conclusion
The dengue testing market is experiencing transformational change fueled by innovation, regulatory shifts, and evolving disease trends. Stakeholders who align technological advancement with adaptive supply strategies and integrated partnerships will be best positioned to address future sector demands and public health priorities.
Table of Contents
1. Preface1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Adoption of smartphone-enabled rapid molecular assays for dengue serotype differentiation in field settings
5.2. Development of multiplex point-of-care diagnostics detecting dengue, Zika, and chikungunya viruses simultaneously
5.3. Integration of CRISPR-Cas based fluorescence readout tests for rapid dengue viral RNA detection at point of care
5.4. Emergence of high-sensitivity immunoassays utilizing nanoparticle-enhanced detection for early dengue diagnosis in low-resource settings
5.5. Regulatory approval trends accelerating commercialization of at-home dengue antigen test kits with digital reporting capabilities
5.6. Implementation of AI-driven algorithms analyzing patient symptoms and test results to predict dengue outbreak hotspots in real time
5.7. Partnership models between biotech firms and public health agencies to scale dengue surveillance via mobile testing units in endemic regions
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Dengue Testing Market, by Test Type
8.1. Introduction
8.2. Antibody Test
8.2.1. Igg Antibody Test
8.2.2. Igm Antibody Test
8.3. Antigen Test
8.3.1. Ns1 Enzyme Linked Immunosorbent Assay
8.3.2. Ns1 Rapid Test
8.4. Molecular Test
8.4.1. Conventional Polymerase Chain Reaction
8.4.2. Real Time Polymerase Chain Reaction
9. Dengue Testing Market, by Technology
9.1. Introduction
9.2. Enzyme Linked Immunosorbent Assay
9.3. Lateral Flow Immunoassay
9.3.1. Colloidal Gold Assay
9.3.2. Fluorescent Immunoassay
9.4. Microarray Technology
9.5. Polymerase Chain Reaction
9.5.1. Conventional Polymerase Chain Reaction
9.5.2. Real Time Polymerase Chain Reaction
10. Dengue Testing Market, by End User
10.1. Introduction
10.2. Clinics
10.3. Diagnostic Laboratories
10.4. Hospitals
10.5. Research Institutes
11. Dengue Testing Market, by Product Type
11.1. Introduction
11.2. Instruments
11.2.1. Readers
11.2.2. Thermal Cyclers
11.3. Software Solutions
11.4. Test Kits
12. Dengue Testing Market, by Setting
12.1. Introduction
12.2. Central Laboratory
12.3. Point Of Care
13. Dengue Testing Market, by Sample Type
13.1. Introduction
13.2. Plasma
13.3. Serum
13.4. Whole Blood
14. Americas Dengue Testing Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Dengue Testing Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Dengue Testing Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Abbott Laboratories
17.3.2. F. Hoffmann-La Roche Ltd
17.3.3. Thermo Fisher Scientific Inc.
17.3.4. Danaher Corporation
17.3.5. bioM9rieux SA
17.3.6. QIAGEN N.V.
17.3.7. Bio-Rad Laboratories, Inc.
17.3.8. Siemens Healthineers AG
17.3.9. Meridian Bioscience, Inc.
17.3.10. Chembio Diagnostics, Inc.
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. DENGUE TESTING MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL DENGUE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL DENGUE TESTING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL DENGUE TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL DENGUE TESTING MARKET SIZE, BY TEST TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL DENGUE TESTING MARKET SIZE, BY TEST TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL DENGUE TESTING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 8. GLOBAL DENGUE TESTING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL DENGUE TESTING MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL DENGUE TESTING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL DENGUE TESTING MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL DENGUE TESTING MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL DENGUE TESTING MARKET SIZE, BY SETTING, 2024 VS 2030 (%)
FIGURE 14. GLOBAL DENGUE TESTING MARKET SIZE, BY SETTING, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL DENGUE TESTING MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2030 (%)
FIGURE 16. GLOBAL DENGUE TESTING MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS DENGUE TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS DENGUE TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES DENGUE TESTING MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES DENGUE TESTING MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA DENGUE TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA DENGUE TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC DENGUE TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC DENGUE TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. DENGUE TESTING MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. DENGUE TESTING MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. DENGUE TESTING MARKET: RESEARCHAI
FIGURE 28. DENGUE TESTING MARKET: RESEARCHSTATISTICS
FIGURE 29. DENGUE TESTING MARKET: RESEARCHCONTACTS
FIGURE 30. DENGUE TESTING MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. DENGUE TESTING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL DENGUE TESTING MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL DENGUE TESTING MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL DENGUE TESTING MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL DENGUE TESTING MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL DENGUE TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL DENGUE TESTING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL DENGUE TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL DENGUE TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL DENGUE TESTING MARKET SIZE, BY ANTIBODY TEST, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL DENGUE TESTING MARKET SIZE, BY ANTIBODY TEST, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL DENGUE TESTING MARKET SIZE, BY IGG ANTIBODY TEST, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL DENGUE TESTING MARKET SIZE, BY IGG ANTIBODY TEST, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL DENGUE TESTING MARKET SIZE, BY IGM ANTIBODY TEST, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL DENGUE TESTING MARKET SIZE, BY IGM ANTIBODY TEST, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL DENGUE TESTING MARKET SIZE, BY ANTIBODY TEST, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL DENGUE TESTING MARKET SIZE, BY ANTIBODY TEST, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL DENGUE TESTING MARKET SIZE, BY ANTIGEN TEST, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL DENGUE TESTING MARKET SIZE, BY ANTIGEN TEST, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL DENGUE TESTING MARKET SIZE, BY NS1 ENZYME LINKED IMMUNOSORBENT ASSAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL DENGUE TESTING MARKET SIZE, BY NS1 ENZYME LINKED IMMUNOSORBENT ASSAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL DENGUE TESTING MARKET SIZE, BY NS1 RAPID TEST, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL DENGUE TESTING MARKET SIZE, BY NS1 RAPID TEST, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL DENGUE TESTING MARKET SIZE, BY ANTIGEN TEST, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL DENGUE TESTING MARKET SIZE, BY ANTIGEN TEST, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL DENGUE TESTING MARKET SIZE, BY MOLECULAR TEST, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL DENGUE TESTING MARKET SIZE, BY MOLECULAR TEST, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL DENGUE TESTING MARKET SIZE, BY CONVENTIONAL POLYMERASE CHAIN REACTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL DENGUE TESTING MARKET SIZE, BY CONVENTIONAL POLYMERASE CHAIN REACTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL DENGUE TESTING MARKET SIZE, BY REAL TIME POLYMERASE CHAIN REACTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL DENGUE TESTING MARKET SIZE, BY REAL TIME POLYMERASE CHAIN REACTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL DENGUE TESTING MARKET SIZE, BY MOLECULAR TEST, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL DENGUE TESTING MARKET SIZE, BY MOLECULAR TEST, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL DENGUE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL DENGUE TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL DENGUE TESTING MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL DENGUE TESTING MARKET SIZE, BY ENZYME LINKED IMMUNOSORBENT ASSAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL DENGUE TESTING MARKET SIZE, BY LATERAL FLOW IMMUNOASSAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL DENGUE TESTING MARKET SIZE, BY LATERAL FLOW IMMUNOASSAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL DENGUE TESTING MARKET SIZE, BY COLLOIDAL GOLD ASSAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL DENGUE TESTING MARKET SIZE, BY COLLOIDAL GOLD ASSAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL DENGUE TESTING MARKET SIZE, BY FLUORESCENT IMMUNOASSAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL DENGUE TESTING MARKET SIZE, BY FLUORESCENT IMMUNOASSAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL DENGUE TESTING MARKET SIZE, BY LATERAL FLOW IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL DENGUE TESTING MARKET SIZE, BY LATERAL FLOW IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL DENGUE TESTING MARKET SIZE, BY MICROARRAY TECHNOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL DENGUE TESTING MARKET SIZE, BY MICROARRAY TECHNOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL DENGUE TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL DENGUE TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL DENGUE TESTING MARKET SIZE, BY CONVENTIONAL POLYMERASE CHAIN REACTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL DENGUE TESTING MARKET SIZE, BY CONVENTIONAL POLYMERASE CHAIN REACTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL DENGUE TESTING MARKET SIZE, BY REAL TIME POLYMERASE CHAIN REACTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL DENGUE TESTING MARKET SIZE, BY REAL TIME POLYMERASE CHAIN REACTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL DENGUE TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL DENGUE TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL DENGUE TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL DENGUE TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL DENGUE TESTING MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL DENGUE TESTING MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL DENGUE TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL DENGUE TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL DENGUE TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL DENGUE TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL DENGUE TESTING MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL DENGUE TESTING MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL DENGUE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL DENGUE TESTING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL DENGUE TESTING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL DENGUE TESTING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL DENGUE TESTING MARKET SIZE, BY READERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL DENGUE TESTING MARKET SIZE, BY READERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL DENGUE TESTING MARKET SIZE, BY THERMAL CYCLERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL DENGUE TESTING MARKET SIZE, BY THERMAL CYCLERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL DENGUE TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL DENGUE TESTING MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL DENGUE TESTING MARKET SIZE, BY SOFTWARE SOLUTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL DENGUE TESTING MARKET SIZE, BY SOFTWARE SOLUTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL DENGUE TESTING MARKET SIZE, BY TEST KITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL DENGUE TESTING MARKET SIZE, BY TEST KITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL DENGUE TESTING MARKET SIZE, BY SETTING, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL DENGUE TESTING MARKET SIZE, BY SETTING, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL DENGUE TESTING MARKET SIZE, BY CENTRAL LABORATORY, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL DENGUE TESTING MARKET SIZE, BY CENTRAL LABORATORY, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL DENGUE TESTING MARKET SIZE, BY POINT OF CARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL DENGUE TESTING MARKET SIZE, BY POINT OF CARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL DENGUE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL DENGUE TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL DENGUE TESTING MARKET SIZE, BY PLASMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL DENGUE TESTING MARKET SIZE, BY PLASMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL DENGUE TESTING MARKET SIZE, BY SERUM, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL DENGUE TESTING MARKET SIZE, BY SERUM, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL DENGUE TESTING MARKET SIZE, BY WHOLE BLOOD, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL DENGUE TESTING MARKET SIZE, BY WHOLE BLOOD, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS DENGUE TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS DENGUE TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS DENGUE TESTING MARKET SIZE, BY ANTIBODY TEST, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS DENGUE TESTING MARKET SIZE, BY ANTIBODY TEST, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS DENGUE TESTING MARKET SIZE, BY ANTIGEN TEST, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS DENGUE TESTING MARKET SIZE, BY ANTIGEN TEST, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS DENGUE TESTING MARKET SIZE, BY MOLECULAR TEST, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS DENGUE TESTING MARKET SIZE, BY MOLECULAR TEST, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS DENGUE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS DENGUE TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS DENGUE TESTING MARKET SIZE, BY LATERAL FLOW IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS DENGUE TESTING MARKET SIZE, BY LATERAL FLOW IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS DENGUE TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS DENGUE TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS DENGUE TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS DENGUE TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS DENGUE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS DENGUE TESTING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS DENGUE TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS DENGUE TESTING MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS DENGUE TESTING MARKET SIZE, BY SETTING, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS DENGUE TESTING MARKET SIZE, BY SETTING, 2025-2030 (USD MILLION)
TABLE 117. AMERICAS DENGUE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 118. AMERICAS DENGUE TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 119. AMERICAS DENGUE TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 120. AMERICAS DENGUE TESTING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 121. UNITED STATES DENGUE TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 122. UNITED STATES DENGUE TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES DENGUE TESTING MARKET SIZE, BY ANTIBODY TEST, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES DENGUE TESTING MARKET SIZE, BY ANTIBODY TEST, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES DENGUE TESTING MARKET SIZE, BY ANTIGEN TEST, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES DENGUE TESTING MARKET SIZE, BY ANTIGEN TEST, 2025-2030 (USD MILLION)
TABLE 127. UNITED STATES DENGUE TESTING MARKET SIZE, BY MOLECULAR TEST, 2018-2024 (USD MILLION)
TABLE 128. UNITED STATES DENGUE TESTING MARKET SIZE, BY MOLECULAR TEST, 2025-2030 (USD MILLION)
TABLE 129. UNITED STATES DENGUE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 130. UNITED STATES DENGUE TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 131. UNITED STATES DENGUE TESTING MARKET SIZE, BY LATERAL FLOW IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 132. UNITED STATES DENGUE TESTING MARKET SIZE, BY LATERAL FLOW IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 133. UNITED STATES DENGUE TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2024 (USD MILLION)
TABLE 134. UNITED STATES DENGUE TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2025-2030 (USD MILLION)
TABLE 135. UNITED STATES DENGUE TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 136. UNITED STATES DENGUE TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 137. UNITED STATES DENGUE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 138. UNITED STATES DENGUE TESTING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 139. UNITED STATES DENGUE TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 140. UNITED STATES DENGUE TESTING MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 141. UNITED STATES DENGUE TESTING MARKET SIZE, BY SETTING, 2018-2024 (USD MILLION)
TABLE 142. UNITED STATES DENGUE TESTING MARKET SIZE, BY SETTING, 2025-2030 (USD MILLION)
TABLE 143. UNITED STATES DENGUE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 144. UNITED STATES DENGUE TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 145. UNITED STATES DENGUE TESTING MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 146. UNITED STATES DENGUE TESTING MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 147. CANADA DENGUE TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 148. CANADA DENGUE TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 149. CANADA DENGUE TESTING MARKET SIZE, BY ANTIBODY TEST, 2018-2024 (USD MILLION)
TABLE 150. CANADA DENGUE TESTING MARKET SIZE, BY ANTIBODY TEST, 2025-2030 (USD MILLION)
TABLE 151. CANADA DENGUE TESTING MARKET SIZE, BY ANTIGEN TEST, 2018-2024 (USD MILLION)
TABLE 152. CANADA DENGUE TESTING MARKET SIZE, BY ANTIGEN TEST, 2025-2030 (USD MILLION)
TABLE 153. CANADA DENGUE TESTING MARKET SIZE, BY MOLECULAR TEST, 2018-2024 (USD MILLION)
TABLE 154. CANADA DENGUE TESTING MARKET SIZE, BY MOLECULAR TEST, 2025-2030 (USD MILLION)
TABLE 155. CANADA DENGUE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 156. CANADA DENGUE TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 157. CANADA DENGUE TESTING MARKET SIZE, BY LATERAL FLOW IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 158. CANADA DENGUE TESTING MARKET SIZE, BY LATERAL FLOW IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 159. CANADA DENGUE TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2024 (USD MILLION)
TABLE 160. CANADA DENGUE TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2025-2030 (USD MILLION)
TABLE 161. CANADA DENGUE TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 162. CANADA DENGUE TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 163. CANADA DENGUE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 164. CANADA DENGUE TESTING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 165. CANADA DENGUE TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 166. CANADA DENGUE TESTING MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 167. CANADA DENGUE TESTING MARKET SIZE, BY SETTING, 2018-2024 (USD MILLION)
TABLE 168. CANADA DENGUE TESTING MARKET SIZE, BY SETTING, 2025-2030 (USD MILLION)
TABLE 169. CANADA DENGUE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 170. CANADA DENGUE TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 171. MEXICO DENGUE TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 172. MEXICO DENGUE TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 173. MEXICO DENGUE TESTING MARKET SIZE, BY ANTIBODY TEST, 2018-2024 (USD MILLION)
TABLE 174. MEXICO DENGUE TESTING MARKET SIZE, BY ANTIBODY TEST, 2025-2030 (USD MILLION)
TABLE 175. MEXICO DENGUE TESTING MARKET SIZE, BY ANTIGEN TEST, 2018-2024 (USD MILLION)
TABLE 176. MEXICO DENGUE TESTING MARKET SIZE, BY ANTIGEN TEST, 2025-2030 (USD MILLION)
TABLE 177. MEXICO DENGUE TESTING MARKET SIZE, BY MOLECULAR TEST, 2018-2024 (USD MILLION)
TABLE 178. MEXICO DENGUE TESTING MARKET SIZE, BY MOLECULAR TEST, 2025-2030 (USD MILLION)
TABLE 179. MEXICO DENGUE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 180. MEXICO DENGUE TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 181. MEXICO DENGUE TESTING MARKET SIZE, BY LATERAL FLOW IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 182. MEXICO DENGUE TESTING MARKET SIZE, BY LATERAL FLOW IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 183. MEXICO DENGUE TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2024 (USD MILLION)
TABLE 184. MEXICO DENGUE TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2025-2030 (USD MILLION)
TABLE 185. MEXICO DENGUE TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 186. MEXICO DENGUE TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 187. MEXICO DENGUE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 188. MEXICO DENGUE TESTING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 189. MEXICO DENGUE TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 190. MEXICO DENGUE TESTING MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 191. MEXICO DENGUE TESTING MARKET SIZE, BY SETTING, 2018-2024 (USD MILLION)
TABLE 192. MEXICO DENGUE TESTING MARKET SIZE, BY SETTING, 2025-2030 (USD MILLION)
TABLE 193. MEXICO DENGUE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 194. MEXICO DENGUE TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 195. BRAZIL DENGUE TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 196. BRAZIL DENGUE TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 197. BRAZIL DENGUE TESTING MARKET SIZE, BY ANTIBODY TEST, 2018-2024 (USD MILLION)
TABLE 198. BRAZIL DENGUE TESTING MARKET SIZE, BY ANTIBODY TEST, 2025-2030 (USD MILLION)
TABLE 199. BRAZIL DENGUE TESTING MARKET SIZE, BY ANTIGEN TEST, 2018-2024 (USD MILLION)
TABLE 200. BRAZIL DENGUE TESTING MARKET SIZE, BY ANTIGEN TEST, 2025-2030 (USD MILLION)
TABLE 201. BRAZIL DENGUE TESTING MARKET SIZE, BY MOLECULAR TEST, 2018-2024 (USD MILLION)
TABLE 202. BRAZIL DENGUE TESTING MARKET SIZE, BY MOLECULAR TEST, 2025-2030 (USD MILLION)
TABLE 203. BRAZIL DENGUE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 204. BRAZIL DENGUE TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 205. BRAZIL DENGUE TESTING MARKET SIZE, BY LATERAL FLOW IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 206. BRAZIL DENGUE TESTING MARKET SIZE, BY LATERAL FLOW IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 207. BRAZIL DENGUE TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2024 (USD MILLION)
TABLE 208. BRAZIL DENGUE TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2025-2030 (USD MILLION)
TABLE 209. BRAZIL DENGUE TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 210. BRAZIL DENGUE TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 211. BRAZIL DENGUE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 212. BRAZIL DENGUE TESTING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 213. BRAZIL DENGUE TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 214. BRAZIL DENGUE TESTING MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 215. BRAZIL DENGUE TESTING MARKET SIZE, BY SETTING, 2018-2024 (USD MILLION)
TABLE 216. BRAZIL DENGUE TESTING MARKET SIZE, BY SETTING, 2025-2030 (USD MILLION)
TABLE 217. BRAZIL DENGUE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 218. BRAZIL DENGUE TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 219. ARGENTINA DENGUE TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 220. ARGENTINA DENGUE TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 221. ARGENTINA DENGUE TESTING MARKET SIZE, BY ANTIBODY TEST, 2018-2024 (USD MILLION)
TABLE 222. ARGENTINA DENGUE TESTING MARKET SIZE, BY ANTIBODY TEST, 2025-2030 (USD MILLION)
TABLE 223. ARGENTINA DENGUE TESTING MARKET SIZE, BY ANTIGEN TEST, 2018-2024 (USD MILLION)
TABLE 224. ARGENTINA DENGUE TESTING MARKET SIZE, BY ANTIGEN TEST, 2025-2030 (USD MILLION)
TABLE 225. ARGENTINA DENGUE TESTING MARKET SIZE, BY MOLECULAR TEST, 2018-2024 (USD MILLION)
TABLE 226. ARGENTINA DENGUE TESTING MARKET SIZE, BY MOLECULAR TEST, 2025-2030 (USD MILLION)
TABLE 227. ARGENTINA DENGUE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 228. ARGENTINA DENGUE TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 229. ARGENTINA DENGUE TESTING MARKET SIZE, BY LATERAL FLOW IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 230. ARGENTINA DENGUE TESTING MARKET SIZE, BY LATERAL FLOW IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 231. ARGENTINA DENGUE TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2024 (USD MILLION)
TABLE 232. ARGENTINA DENGUE TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2025-2030 (USD MILLION)
TABLE 233. ARGENTINA DENGUE TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 234. ARGENTINA DENGUE TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 235. ARGENTINA DENGUE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 236. ARGENTINA DENGUE TESTING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 237. ARGENTINA DENGUE TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 238. ARGENTINA DENGUE TESTING MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 239. ARGENTINA DENGUE TESTING MARKET SIZE, BY SETTING, 2018-2024 (USD MILLION)
TABLE 240. ARGENTINA DENGUE TESTING MARKET SIZE, BY SETTING, 2025-2030 (USD MILLION)
TABLE 241. ARGENTINA DENGUE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 242. ARGENTINA DENGUE TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 243. EUROPE, MIDDLE EAST & AFRICA DENGUE TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 244. EUROPE, MIDDLE EAST & AFRICA DENGUE TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 245. EUROPE, MIDDLE EAST & AFRICA DENGUE TESTING MARKET SIZE, BY ANTIBODY TEST, 2018-2024 (USD MILLION)
TABLE 246. EUROPE, MIDDLE EAST & AFRICA DENGUE TESTING MARKET SIZE, BY ANTIBODY TEST, 2025-2030 (USD MILLION)
TABLE 247. EUROPE, MIDDLE EAST & AFRICA DENGUE TESTING MARKET SIZE, BY ANTIGEN TEST, 2018-2024 (USD MILLION)
TABLE 248. EUROPE, MIDDLE EAST & AFRICA DENGUE TESTING MARKET SIZE, BY ANTIGEN TEST, 2025-2030 (USD MILLION)
TABLE 249. EUROPE, MIDDLE EAST & AFRICA DENGUE TESTING MARKET SIZE, BY MOLECULAR TEST, 2018-2024 (USD MILLION)
TABLE 250. EUROPE, MIDDLE EAST & AFRICA DENGUE TESTING MARKET SIZE, BY MOLECULAR TEST, 2025-2030 (USD MILLION)
TABLE 251. EUROPE, MIDDLE EAST & AFRICA DENGUE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 252. EUROPE, MIDDLE EAST & AFRICA DENGUE TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 253. EUROPE, MIDDLE EAST & AFRICA DENGUE TESTING MARKET SIZE, BY LATERAL FLOW IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 254. EUROPE, MIDDLE EAST & AFRICA DENGUE TESTING MARKET SIZE, BY LATERAL FLOW IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 255. EUROPE, MIDDLE EAST & AFRICA DENGUE TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2024 (USD MILLION)
TABLE 256. EUROPE, MIDDLE EAST & AFRICA DENGUE TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2025-2030 (USD MILLION)
TABLE 257. EUROPE, MIDDLE EAST & AFRICA DENGUE TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 258. EUROPE, MIDDLE EAST & AFRICA DENGUE TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 259. EUROPE, MIDDLE EAST & AFRICA DENGUE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 260. EUROPE, MIDDLE EAST & AFRICA DENGUE TESTING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 261. EUROPE, MIDDLE EAST & AFRICA DENGUE TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 262. EUROPE, MIDDLE EAST & AFRICA DENGUE TESTING MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 263. EUROPE, MIDDLE EAST & AFRICA DENGUE TESTING MARKET SIZE, BY SETTING, 2018-2024 (USD MILLION)
TABLE 264. EUROPE, MIDDLE EAST & AFRICA DENGUE TESTING MARKET SIZE, BY SETTING, 2025-2030 (USD MILLION)
TABLE 265. EUROPE, MIDDLE EAST & AFRICA DENGUE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 266. EUROPE, MIDDLE EAST & AFRICA DENGUE TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 267. EUROPE, MIDDLE EAST & AFRICA DENGUE TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 268. EUROPE, MIDDLE EAST & AFRICA DENGUE TESTING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 269. UNITED KINGDOM DENGUE TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 270. UNITED KINGDOM DENGUE TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 271. UNITED KINGDOM DENGUE TESTING MARKET SIZE, BY ANTIBODY TEST, 2018-2024 (USD MILLION)
TABLE 272. UNITED KINGDOM DENGUE TESTING MARKET SIZE, BY ANTIBODY TEST, 2025-2030 (USD MILLION)
TABLE 273. UNITED KINGDOM DENGUE TESTING MARKET SIZE, BY ANTIGEN TEST, 2018-2024 (USD MILLION)
TABLE 274. UNITED KINGDOM DENGUE TESTING MARKET SIZE, BY ANTIGEN TEST, 2025-2030 (USD MILLION)
TABLE 275. UNITED KINGDOM DENGUE TESTING MARKET SIZE, BY MOLECULAR TEST, 2018-2024 (USD MILLION)
TABLE 276. UNITED KINGDOM DENGUE TESTING MARKET SIZE, BY MOLECULAR TEST, 2025-2030 (USD MILLION)
TABLE 277. UNITED KINGDOM DENGUE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 278. UNITED KINGDOM DENGUE TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 279. UNITED KINGDOM DENGUE TESTING MARKET SIZE, BY LATERAL FLOW IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 280. UNITED KINGDOM DENGUE TESTING MARKET SIZE, BY LATERAL FLOW IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 281. UNITED KINGDOM DENGUE TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2024 (USD MILLION)
TABLE 282. UNITED KINGDOM DENGUE TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2025-2030 (USD MILLION)
TABLE 283. UNITED KINGDOM DENGUE TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 284. UNITED KINGDOM DENGUE TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 285. UNITED KINGDOM DENGUE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 286. UNITED KINGDOM DENGUE TESTING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 287. UNITED KINGDOM DENGUE TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 288. UNITED KINGDOM DENGUE TESTING MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 289. UNITED KINGDOM DENGUE TESTING MARKET SIZE, BY SETTING, 2018-2024 (USD MILLION)
TABLE 290. UNITED KINGDOM DENGUE TESTING MARKET SIZE, BY SETTING, 2025-2030 (USD MILLION)
TABLE 291. UNITED KINGDOM DENGUE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 292. UNITED KINGDOM DENGUE TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 293. GERMANY DENGUE TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 294. GERMANY DENGUE TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 295. GERMANY DENGUE TESTING MARKET SIZE, BY ANTIBODY TEST, 2018-2024 (USD MILLION)
TABLE 296. GERMANY DENGUE TESTING MARKET SIZE, BY ANTIBODY TEST, 2025-2030 (USD MILLION)
TABLE 297. GERMANY DENGUE TESTING MARKET SIZE, BY ANTIGEN TEST, 2018-2024 (USD MILLION)
TABLE 298. GERMANY DENGUE TESTING MARKET SIZE, BY ANTIGEN TEST, 2025-2030 (USD MILLION)
TABLE 299. GERMANY DENGUE TESTING MARKET SIZE, BY MOLECULAR TEST, 2018-2024 (USD MILLION)
TABLE 300. GERMANY DENGUE TESTING MARKET SIZE, BY MOLECULAR TEST, 2025-2030 (USD MILLION)
TABLE 301. GERMANY DENGUE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 302. GERMANY DENGUE TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 303. GERMANY DENGUE TESTING MARKET SIZE, BY LATERAL FLOW IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 304. GERMANY DENGUE TESTING MARKET SIZE, BY LATERAL FLOW IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 305. GERMANY DENGUE TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2024 (USD MILLION)
TABLE 306. GERMANY DENGUE TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2025-2030 (USD MILLION)
TABLE 307. GERMANY DENGUE TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 308. GERMANY DENGUE TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 309. GERMANY DENGUE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 310. GERMANY DENGUE TESTING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 311. GERMANY DENGUE TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 312. GERMANY DENGUE TESTING MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 313. GERMANY DENGUE TESTING MARKET SIZE, BY SETTING, 2018-2024 (USD MILLION)
TABLE 314. GERMANY DENGUE TESTING MARKET SIZE, BY SETTING, 2025-2030 (USD MILLION)
TABLE 315. GERMANY DENGUE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 316. GERMANY DENGUE TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 317. FRANCE DENGUE TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 318. FRANCE DENGUE TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 319. FRANCE DENGUE TESTING MARKET SIZE, BY ANTIBODY TEST, 2018-2024 (USD MILLION)
TABLE 320. FRANCE DENGUE TESTING MARKET SIZE, BY ANTIBODY TEST, 2025-2030 (USD MILLION)
TABLE 321. FRANCE DENGUE TESTING MARKET SIZE, BY ANTIGEN TEST, 2018-2024 (USD MILLION)
TABLE 322. FRANCE DENGUE TESTING MARKET SIZE, BY ANTIGEN TEST, 2025-2030 (USD MILLION)
TABLE 323. FRANCE DENGUE TESTING MARKET SIZE, BY MOLECULAR TEST, 2018-2024 (USD MILLION)
TABLE 324. FRANCE DENGUE TESTING MARKET SIZE, BY MOLECULAR TEST, 2025-2030 (USD MILLION)
TABLE 325. FRANCE DENGUE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 326. FRANCE DENGUE TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 327. FRANCE DENGUE TESTING MARKET SIZE, BY LATERAL FLOW IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 328. FRANCE DENGUE TESTING MARKET SIZE, BY LATERAL FLOW IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 329. FRANCE DENGUE TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2018-2024 (USD MILLION)
TABLE 330. FRANCE DENGUE TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, 2025-2030 (USD MILLION)
TABLE 331. FRANCE DENGUE TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 332. FRANCE DENGUE TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 333. FRANCE DENGUE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 334. FRANCE DENGUE TESTING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 335. FRANCE DENGUE TESTING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 336. FRANCE DENGUE TESTING MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 337. FRANCE DENGUE TESTING MARKET SIZE, BY SETTING, 2018-2024 (USD MILLION)
TABLE 338. FRANCE DENGUE TESTING MARKET SIZE, BY SETTING, 2025-2030 (USD MILLION)
TABLE 339. FRANCE DENGUE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 340. FRANCE DENGUE TESTING MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 341. RUSSIA DENGUE TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 342. RUSSIA DENGUE TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 343. RUSSIA DENGUE TESTING MARKET SIZE, BY ANTIBODY TEST, 2018-2024 (USD MILLION)
TABLE 344. RUSSIA DENGUE TESTING MARKET SIZE, BY ANTIBODY TEST, 2025-2030 (USD MILLION)
TABLE 345. RUSSIA DENGUE TESTING MARKET SIZE, BY ANTIGEN TEST, 2018-2024 (USD MILLION)
TABLE 346. RUSSIA DENGUE TESTING MARKET SIZE, BY ANTIGEN TEST, 2025-2030 (USD MILLION)
TABLE 347. RUSSIA DENGUE TESTING MARKET SIZE, BY MOLECULAR TEST, 2018-2024 (USD MILLION)
TABLE 348. RUSSIA DENGUE TESTING MARKET SIZE, BY MOLECULAR TEST, 2025-2030 (USD MILLION)
TABLE 349. RUSSIA DENGUE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 350. RUSSIA DENGUE TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 351. RUSSIA DENGUE TESTING MARKET SIZE, BY LATERAL FLOW IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 35
Samples
LOADING...
Companies Mentioned
The major companies profiled in this Dengue Testing market report include:- Abbott Laboratories
- F. Hoffmann-La Roche Ltd
- Thermo Fisher Scientific Inc.
- Danaher Corporation
- bioM9rieux SA
- QIAGEN N.V.
- Bio-Rad Laboratories, Inc.
- Siemens Healthineers AG
- Meridian Bioscience, Inc.
- Chembio Diagnostics, Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 197 |
| Published | August 2025 |
| Forecast Period | 2025 - 2030 |
| Estimated Market Value ( USD | $ 558.61 Million |
| Forecasted Market Value ( USD | $ 738.13 Million |
| Compound Annual Growth Rate | 5.7% |
| Regions Covered | Global |
| No. of Companies Mentioned | 11 |
